Multiple Myeloma and Amyloidosis Program

If you’ve been diagnosed with the rare diseases of multiple myeloma or amyloidosis, it’s important to be evaluated by hematology experts before beginning treatment. We can help.

Karmanos’ Multiple Myeloma and Amyloidosis Specialists

Our Multiple Myeloma and Amyloidosis Multidisciplinary Team sees between 230 and 250 new multiple myeloma patients and between 30 and 50 new amyloidosis patients each year. 

The team spans many disciplines, including hematologists, medical oncologists, specialized nurse practitioners, bone marrow transplant specialists, radiologists, pathologists, cardiologists, nephrologists, radiation oncologists, orthopedic surgeons, dietitians and social workers.  The team is entirely focused on treating multiple myeloma and amyloidosis and shares its collective expertise to create a customized treatment plan for each patient.

Our team of researchers not only has vast clinical expertise, but also years of clinical research experience. We have one of the largest myeloma bone marrow transplant programs in the country and are one of the few centers in the region offering investigational cellular therapies such as CAR-T cells to patients with Multiple Myeloma. 

In fact, Karmanos also has more active clinical trials for patients with multiple myeloma and amyloidosis than any other center in the state of Michigan. The team collaborates with basic scientists to better understand multiple myeloma and amyloidosis and to bring these new therapies to the clinic.

Evaluation & Diagnosis

Every new multiple myeloma or amyloidosis patient seen in consultation at Karmanos has his or her case reviewed in the weekly MDT meeting to facilitate a customized treatment plan and timely referral to the various subspecialists needed for optimal care. During your initial visit at a Karmanos location, a physician will review your medical records, medical history and review your x-rays and pathology slides.

Innovative, Individualized Care

Here’s what patients can expect from our Multiple Myeloma and Amyloidosis Multidisciplinary Team:

  • A passionate, caring, expert team, giving you the best chance of success.
  • A collaborative approach that considers all available treatment options, including clinical trials, for your specific type of cancer.
  • A carefully constructed treatment plan designed to achieve the best possible outcome.
  • Respectful, compassionate care that is responsive to your emotional needs and lifestyle.
  • Proactive, timely communication with you and your loved ones, and your personal physician.

Appointment Information

Request an Appointment Online Request an Appointment By Phone

The Latest From Karmanos Cancer Institute

News

IN THE NEWS: Metro Detroiter spreads light 10 years into stage IV breast cancer fight

WXYZ Detroit, Channel 7 Joanne Ortolan of Grosse Ile was diagnosed with stage IV breast cancer in 2013. She was honored ahead of the 10th Annual P...

Read More

IN THE NEWS: Detroit Tigers, Karmanos Team Up to Honor Survivors & Pink Out the Park

CBS Detroit Breast cancer survivors will be honored at the 10th Annual Pink Out the Park with the Detroit Tigers. This game helps McLaren Health C...

Read More

Karmanos Cancer Institute and the Detroit Tigers honor survivors and promote breast health at 10th Annual Pink Out the Park game

Barbara Ann Karmanos Cancer Institute , in partnership with the Detroit Tigers and McLaren Health Care, the official health care system of the Tig...

Read More
News

Eliminating health disparities around multiple myeloma

Listen Now

ACS CAN Michigan Candid Connection

Listen Now

How Multiple Myeloma affects the African American community

Listen Now